04/25/2026
The three amigos of the GLPs are semaglutide, tirzepatide, and Retatrutide. They're also known as Ozempic/Wegovy, Monjauro/Zepbound and Reta which doesnt yet have a trademark name but expected to be on the market at the end of 2026 or beginning of 2027.
They function by mimicking the GLP-1 hormone to regulate blood sugar and suppress appetite. This leads to many who research these products to potentially experience weight loss, improve A1C levels, reduce and potentially eliminate body inflammation. Improved cholesterol and reduced risks in cardiovascular events and stroke.
Now, I cant go down the rabbit hole too much without upsetting page guidlines. I've already got warnings for the content on my page. So if you'd like to get additional information on these three research peptides or want know about other therapeutic peptides that are available feel free to reach out by sending me a message on FB messenger or on WhatsApp.